WASHINGTON – U.S. Senator Maggie Hassan (D-NH) is calling for answers from the Healthcare Private Equity Association about the impact of private equity investment in the health care sector.
As Senator Hassan discusses in her letter, private equity groups have increasingly acquired physician practice groups, resulting in many local doctors working not for themselves or local hospitals, but for these increasingly large staffing practice groups.
Senator Hassan is raising concerns over the impact that private equity firms have on clinical independence, as well as surprise medical billing.
"Further, this trend has had devastating impacts on many patients who received large and unexpected medical bills from hospitals that are effectively staffed by private equity firms. In these cases, even though patients visited hospitals within their insurers’ network, the patients were hit by surprise medical bills because the doctor who saw them was employed by an out-of-network staffing firm," wrote Senator Hassan.
Senator Hassan also raises questions about if private equity firms are complying with the letter and spirit of prohibitions on "corporate practice of medicine," which protects patients and doctors by requiring doctors to work for themselves or other doctors, not non-medical corporations.
Senator Hassan is calling for details on private equity firms' acquisition of physician groups over the last ten years, safeguards to ensure physician independence, and efforts to limit surprise medical bills.
The letter that Senator Hassan sent is part of her ongoing, bipartisan efforts to end surprise medical bills. Senators Hassan and Bill Cassidy (R-LA) worked for months with members from both parties to craft the STOP Surprise Medical Bills Act to end this practice. Last year, the Senate Health, Education, Labor, and Pensions Committee – on which both Senators serve – and the House Energy and Commerce Committee released a bipartisan, bicameral compromise that incorporated considerable feedback and work from the two Senators.
Read Senator Hassan's letter here or below:
Dear Ms. Daych:
As private equity investment in the health care sector surges, I write to urge your member companies to publicly disclose information necessary to give Congress and the American people a fuller picture of the dramatic changes such investment is causing. In particular, I am concerned that private equity investment in health care is driving prices up for patients, including through practices such as surprise medical billing. I am also concerned that private equity companies are interfering in the ability of local doctors to provide the best possible care to their patients.
Over the past decade, private equity groups have increasingly acquired physician practice groups and consolidated them into large nationwide staffing firms. As a result, many local doctors, who keep their communities healthy, no longer work for themselves or their local hospitals, but are employees of practice groups that staff those hospitals.
This raises serious questions about whether private equity firms restrict clinical independence. Further, this trend has had devastating impacts on many patients who received large and unexpected medical bills from hospitals that are effectively staffed by private equity firms. In these cases, even though patients visited hospitals within their insurers’ network, the patients were hit by surprise medical bills because the doctor who saw them was employed by an out-of-network staffing firm.
Private equity firms must comply with state laws prohibiting what is known as the “corporate practice of medicine.” These laws prohibit corporations from practicing medicine or employing physicians to perform medical services. These laws are intended to prevent the commercialization of the practice of medicine, so that patients are not harmed by conflicts of interest between a physician’s duty to his or her patients and a corporation’s duty to its shareholders. Although these state laws vary widely and have differing exceptions, the trends outlined above raise general questions regarding whether and how private equity firms are complying with both the letter and the spirit of prohibitions on the corporate practice of medicine.
Given these serious concerns, I ask that your members provide transparency into private equity’s role in the health care sector by answering the following questions by November 22, 2020:
i. The Blackstone Group Inc.
ii. The Carlyle Group
iii. Kohlberg Kravis Roberts & Co. (“KKR”)
Thank you for your attention to this important matter.